middle.news
Nanosonics broadens CORIS reach with second FDA clearance
9:45am on Wednesday 11th of November, 2026 AEDT
•
Healthcare
Read Story
Nanosonics broadens CORIS reach with second FDA clearance
9:45am on Wednesday 11th of November, 2026 AEDT
Key Points
Second FDA 510(k) clearance for CORIS
Expanded indications include high-volume colonoscopes and gastroscopes
Supports planned US commercial launch activities
No launch date, sales forecast or earnings impact disclosed
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Nanosonics (ASX:NAN)
OPEN ARTICLE